Xi Tian

1.8k total citations
76 papers, 1.1k citations indexed

About

Xi Tian is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Xi Tian has authored 76 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pulmonary and Respiratory Medicine, 33 papers in Molecular Biology and 20 papers in Oncology. Recurrent topics in Xi Tian's work include Ferroptosis and cancer prognosis (25 papers), Renal cell carcinoma treatment (22 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Xi Tian is often cited by papers focused on Ferroptosis and cancer prognosis (25 papers), Renal cell carcinoma treatment (22 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Xi Tian collaborates with scholars based in China, United States and Singapore. Xi Tian's co-authors include Wenhao Xu, Aihetaimujiang Anwaier, Yuanyuan Qu, Dingwei Ye, Wangrui Liu, Jiaqi Su, Hailiang Zhang, Guohai Shi, Wenkai Zhu and Jiechao Ma and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Xi Tian

65 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xi Tian China 19 500 347 274 258 163 76 1.1k
Rong Yang China 19 515 1.0× 335 1.0× 178 0.6× 152 0.6× 102 0.6× 79 1.1k
Hong Zhu China 18 371 0.7× 324 0.9× 169 0.6× 437 1.7× 151 0.9× 62 1.3k
Xuehua Zhu China 18 519 1.0× 235 0.7× 168 0.6× 202 0.8× 131 0.8× 44 1.0k
Rongzhen Luo China 19 482 1.0× 191 0.6× 262 1.0× 460 1.8× 207 1.3× 55 1.1k
Christos Valavanis Greece 19 653 1.3× 244 0.7× 218 0.8× 245 0.9× 86 0.5× 40 1.2k
Hye Won Lee South Korea 19 484 1.0× 318 0.9× 259 0.9× 310 1.2× 158 1.0× 53 1.2k
Li Yan China 18 393 0.8× 178 0.5× 206 0.8× 336 1.3× 81 0.5× 54 872
Noushin Niknafs United States 12 598 1.2× 139 0.4× 389 1.4× 341 1.3× 163 1.0× 27 1.1k

Countries citing papers authored by Xi Tian

Since Specialization
Citations

This map shows the geographic impact of Xi Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi Tian more than expected).

Fields of papers citing papers by Xi Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xi Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi Tian. The network helps show where Xi Tian may publish in the future.

Co-authorship network of co-authors of Xi Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Xi Tian. A scholar is included among the top collaborators of Xi Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xi Tian. Xi Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Zhongyuan, Aihetaimujiang Anwaier, Xi Tian, et al.. (2025). Spatially segregated APOE+ macrophages restrict immunotherapy efficacy in clear cell renal cell carcinoma. Theranostics. 15(11). 5312–5336. 2 indexed citations
2.
Ye, Shiqi, Jian‐Feng Xiang, Siqi Zhou, et al.. (2025). Polystyrene Microplastics Exposure Aggravates Clear Cell Renal Cell Carcinoma Progression via the NF‐κB and TGF‐β Signaling Pathways. Advanced Science. 13(8). e18500–e18500.
3.
4.
Anwaier, Aihetaimujiang, Yuanyuan Qu, Shiqi Ye, et al.. (2025). Genomic landscape and molecular evolutionary trajectories of renal epithelioid angiomyolipoma and benign angiomyolipoma. Neoplasia. 68. 101212–101212.
5.
Jiang, Biao, Wenjie Lu, Xi Tian, et al.. (2025). Regulation of pyroptosis by sodium butyrate supplementation mitigates cold stress-induced intestinal damage in Danzhou chicken. Journal of Thermal Biology. 132. 104239–104239.
6.
Tian, Xi, Sujun Zhang, Liqiang Gu, et al.. (2025). Dynamic Metabolite Profile Changes in Semen Ziziphi Spinosae During Ripening. Rapid Communications in Mass Spectrometry. 39(11). e10024–e10024.
7.
Wang, Zhongyuan, Aihetaimujiang Anwaier, Shiwei Liu, et al.. (2025). Hsa_circ_0038737 promotes PARPi resistance in castration-resistant prostate cancer via IGF2BP3-mediated DNPH1 mRNA stabilization. Molecular Cancer. 24(1). 238–238.
8.
Dai, Yue, Yayun Liu, Xi Tian, et al.. (2025). Overcoming chemoresistance in non-small cell lung cancer: Insights into the influence of inflammatory factors on treatment response. World Journal of Clinical Oncology. 16(10). 112097–112097. 1 indexed citations
9.
Wei, Guoen, Pingjun Sun, Shuoshuo Li, et al.. (2024). Trade-offs and synergies pattern evolution of ecosystem structure-resilience-activity-services (SRAS) in the Belt and Road Initiative region. Resources Conservation and Recycling. 211. 107883–107883. 7 indexed citations
10.
Xu, Wenhao, Xi Tian, Shiqi Ye, et al.. (2024). Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma. SHILAP Revista de lepidopterología. 5(1). e461–e461. 27 indexed citations
11.
Tian, Xi, Shiqi Ye, Yue Wang, et al.. (2024). Systematic multiomics analysis and in vitro experiments suggest that ITGA5 could serve as a promising therapeutic target for ccRCC. Cancer Cell International. 24(1). 363–363.
12.
Zhang, Zi-Hao, Yue Wang, Ya Zhang, et al.. (2023). The function and mechanisms of action of circular RNAs in Urologic Cancer. Molecular Cancer. 22(1). 61–61. 56 indexed citations
13.
Sun, Shilin, et al.. (2023). Study on mechanism of hepatoprotective effect of Chrysanthemum morifolium Ramat. based on metabolomics with network analysis and network pharmacology. Journal of Chromatography B. 1222. 123711–123711. 3 indexed citations
14.
Kang, Ning, Zhen Li, Xi Tian, et al.. (2022). Perirenal Fat Thickness Significantly Associated with Prognosis of Metastatic Renal Cell Cancer Patients Receiving Anti-VEGF Therapy. Nutrients. 14(16). 3388–3388. 7 indexed citations
15.
16.
Anwaier, Aihetaimujiang, Wenhao Xu, Xi Tian, et al.. (2022). ♣Evaluation of clinicopathological profiles and development of a risk model in renal epithelioid angiomyolipoma patients: a large-scale retrospective cohort study. BMC Urology. 22(1). 148–148. 4 indexed citations
17.
Xu, Wenhao, Wenkai Zhu, Wangrui Liu, et al.. (2021). Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma. Frontiers in Immunology. 12. 734646–734646. 18 indexed citations
18.
Xu, Wenhao, Wenkai Zhu, Xi Tian, et al.. (2021). Integrative 5-Methylcytosine Modification Immunologically Reprograms Tumor Microenvironment Characterizations and Phenotypes of Clear Cell Renal Cell Carcinoma. Frontiers in Cell and Developmental Biology. 9. 772436–772436. 8 indexed citations
19.
Xu, Wenhao, Aihetaimujiang Anwaier, Chunguang Ma, et al.. (2021). Prognostic Immunophenotyping Clusters of Clear Cell Renal Cell Carcinoma Defined by the Unique Tumor Immune Microenvironment. Frontiers in Cell and Developmental Biology. 9. 785410–785410. 17 indexed citations
20.
Yong, Kol Jia, Chong Gao, Joline S.J. Lim, et al.. (2013). Oncofetal Gene SALL4 in Aggressive Hepatocellular Carcinoma. New England Journal of Medicine. 368(24). 2266–2276. 198 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rong Yang Breakdown of academic impact, for papers by Hong Zhu Breakdown of academic impact, for papers by Xuehua Zhu Breakdown of academic impact, for papers by Rongzhen Luo Breakdown of academic impact, for papers by Christos Valavanis Breakdown of academic impact, for papers by Hye Won Lee Breakdown of academic impact, for papers by Li Yan Breakdown of academic impact, for papers by Noushin Niknafs
Rankless by CCL
2026